HEADER ANTIBIOTIC 30-APR-01 1IJU TITLE HUMAN BETA-DEFENSIN-1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-DEFENSIN 1; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: HBD-1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THIS PEPTIDE WAS CHEMICALLY SYNTHESIZED. THE SEQUENCE SOURCE 4 OF THIS PEPTIDE OCCURS NATURALLY IN HUMANS (HOMO SAPIENS). KEYWDS DEFENSIN, HUMAN BETA-DEFENSIN-1, BETA-DEFENSIN, ANTIBIOTIC EXPDTA X-RAY DIFFRACTION AUTHOR D.M.HOOVER,J.LUBKOWSKI REVDAT 6 30-OCT-24 1IJU 1 REMARK REVDAT 5 03-APR-24 1IJU 1 REMARK REVDAT 4 13-JUL-11 1IJU 1 VERSN REVDAT 3 24-FEB-09 1IJU 1 VERSN REVDAT 2 01-APR-03 1IJU 1 JRNL REVDAT 1 24-OCT-01 1IJU 0 JRNL AUTH D.M.HOOVER,O.CHERTOV,J.LUBKOWSKI JRNL TITL THE STRUCTURE OF HUMAN BETA-DEFENSIN-1: NEW INSIGHTS INTO JRNL TITL 2 STRUCTURAL PROPERTIES OF BETA-DEFENSINS. JRNL REF J.BIOL.CHEM. V. 276 39021 2001 JRNL REFN ISSN 0021-9258 JRNL PMID 11486002 JRNL DOI 10.1074/JBC.M103830200 REMARK 2 REMARK 2 RESOLUTION. 1.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.1 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.175 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.168 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.217 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 4.400 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1110 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 25193 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.159 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.159 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.199 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 1019 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 21080 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1084 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 47 REMARK 3 SOLVENT ATOMS : 271 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 1350.0 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 1040.0 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 1 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 6199 REMARK 3 NUMBER OF RESTRAINTS : 5551 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 ANGLE DISTANCES (A) : 0.020 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.028 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.050 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.050 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.010 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.000 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.080 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1IJU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-MAY-01. REMARK 100 THE DEPOSITION ID IS D_1000013345. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-MAR-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X9B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : SI CRYSTAL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26325 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.400 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.04200 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 27.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.45 REMARK 200 COMPLETENESS FOR SHELL (%) : 64.1 REMARK 200 DATA REDUNDANCY IN SHELL : 1.80 REMARK 200 R MERGE FOR SHELL (I) : 0.24200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: HUMAN BETA-DEFENSIN-1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 30.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.77 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, AMMONIUM SULFATE, SODIUM REMARK 280 ACETATE, GLYCEROL, PH 4.6, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 285K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 13.40700 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5, 6, 7 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3780 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9150 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -127.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 26.81400 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1620 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 4950 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -54.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 7 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1350 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 5020 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -56.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 TYR B 3 CB - CG - CD1 ANGL. DEV. = -3.9 DEGREES REMARK 500 CYS D 17 CA - CB - SG ANGL. DEV. = 7.5 DEGREES REMARK 500 ARG D 29 NE - CZ - NH1 ANGL. DEV. = -3.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 28 60.60 66.93 REMARK 500 SER B 15 -122.98 -114.73 REMARK 500 SER B 15 -120.72 -115.94 REMARK 500 PHE B 20 -4.15 82.28 REMARK 500 GLN B 24 50.00 -161.02 REMARK 500 GLN B 24 50.00 -141.90 REMARK 500 TYR C 28 62.97 61.29 REMARK 500 TYR D 14 54.72 -96.28 REMARK 500 SER D 15 -125.29 174.26 REMARK 500 SER D 15 -149.36 -84.96 REMARK 500 PRO D 18 -176.52 -69.27 REMARK 500 ILE D 19 132.01 -24.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 103 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 104 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 105 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 106 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 D 107 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 108 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 D 109 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL C 102 DBREF 1IJU A 1 36 UNP P60022 BD01_HUMAN 33 68 DBREF 1IJU B 1 36 UNP P60022 BD01_HUMAN 33 68 DBREF 1IJU C 1 36 UNP P60022 BD01_HUMAN 33 68 DBREF 1IJU D 1 36 UNP P60022 BD01_HUMAN 33 68 SEQRES 1 A 36 ASP HIS TYR ASN CYS VAL SER SER GLY GLY GLN CYS LEU SEQRES 2 A 36 TYR SER ALA CYS PRO ILE PHE THR LYS ILE GLN GLY THR SEQRES 3 A 36 CYS TYR ARG GLY LYS ALA LYS CYS CYS LYS SEQRES 1 B 36 ASP HIS TYR ASN CYS VAL SER SER GLY GLY GLN CYS LEU SEQRES 2 B 36 TYR SER ALA CYS PRO ILE PHE THR LYS ILE GLN GLY THR SEQRES 3 B 36 CYS TYR ARG GLY LYS ALA LYS CYS CYS LYS SEQRES 1 C 36 ASP HIS TYR ASN CYS VAL SER SER GLY GLY GLN CYS LEU SEQRES 2 C 36 TYR SER ALA CYS PRO ILE PHE THR LYS ILE GLN GLY THR SEQRES 3 C 36 CYS TYR ARG GLY LYS ALA LYS CYS CYS LYS SEQRES 1 D 36 ASP HIS TYR ASN CYS VAL SER SER GLY GLY GLN CYS LEU SEQRES 2 D 36 TYR SER ALA CYS PRO ILE PHE THR LYS ILE GLN GLY THR SEQRES 3 D 36 CYS TYR ARG GLY LYS ALA LYS CYS CYS LYS HET SO4 A 103 5 HET GOL A 101 6 HET SO4 B 104 5 HET SO4 B 105 5 HET SO4 C 106 5 HET SO4 C 108 5 HET GOL C 102 6 HET SO4 D 107 5 HET SO4 D 109 5 HETNAM SO4 SULFATE ION HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 5 SO4 7(O4 S 2-) FORMUL 6 GOL 2(C3 H8 O3) FORMUL 14 HOH *271(H2 O) HELIX 1 1 ASP A 1 SER A 8 1 8 HELIX 2 2 ASP B 1 SER B 8 1 8 HELIX 3 3 ASP C 1 SER C 8 1 8 HELIX 4 4 ASP D 1 SER D 8 1 8 SHEET 1 A 3 GLN A 11 LEU A 13 0 SHEET 2 A 3 ALA A 32 LYS A 36 -1 N LYS A 33 O LEU A 13 SHEET 3 A 3 LYS A 22 CYS A 27 -1 N LYS A 22 O LYS A 36 SHEET 1 B 3 GLN B 11 LEU B 13 0 SHEET 2 B 3 ALA B 32 LYS B 36 -1 N LYS B 33 O LEU B 13 SHEET 3 B 3 LYS B 22 CYS B 27 -1 N LYS B 22 O LYS B 36 SHEET 1 C 3 GLN C 11 LEU C 13 0 SHEET 2 C 3 ALA C 32 LYS C 36 -1 N LYS C 33 O LEU C 13 SHEET 3 C 3 LYS C 22 CYS C 27 -1 N LYS C 22 O LYS C 36 SHEET 1 D 3 GLN D 11 LEU D 13 0 SHEET 2 D 3 ALA D 32 LYS D 36 -1 N LYS D 33 O LEU D 13 SHEET 3 D 3 LYS D 22 CYS D 27 -1 N LYS D 22 O LYS D 36 SSBOND 1 CYS A 5 CYS A 34 1555 1555 2.05 SSBOND 2 CYS A 12 CYS A 27 1555 1555 2.03 SSBOND 3 CYS A 17 CYS A 35 1555 1555 2.03 SSBOND 4 CYS B 5 CYS B 34 1555 1555 2.07 SSBOND 5 CYS B 12 CYS B 27 1555 1555 2.06 SSBOND 6 CYS B 17 CYS B 35 1555 1555 2.01 SSBOND 7 CYS C 5 CYS C 34 1555 1555 2.05 SSBOND 8 CYS C 12 CYS C 27 1555 1555 2.08 SSBOND 9 CYS C 17 CYS C 35 1555 1555 2.05 SSBOND 10 CYS D 5 CYS D 34 1555 1555 2.07 SSBOND 11 CYS D 12 CYS D 27 1555 1555 2.05 SSBOND 12 CYS D 17 CYS D 35 1555 1555 2.00 SITE 1 AC1 11 ASP A 1 HIS A 2 CYS A 27 TYR A 28 SITE 2 AC1 11 ARG A 29 HOH A 214 HOH A 243 HOH A 246 SITE 3 AC1 11 HOH A 263 TYR B 3 HOH B 239 SITE 1 AC2 10 TYR A 3 HOH A 246 ASP B 1 HIS B 2 SITE 2 AC2 10 CYS B 27 TYR B 28 ARG B 29 HOH B 239 SITE 3 AC2 10 HOH B 301 HOH B 335 SITE 1 AC3 8 SER B 8 LYS B 31 LYS B 36 HOH B 229 SITE 2 AC3 8 HOH B 380 HOH B 391 HOH B 412 HOH B 456 SITE 1 AC4 11 ASP C 1 HIS C 2 CYS C 27 TYR C 28 SITE 2 AC4 11 ARG C 29 HOH C 208 HOH C 230 HOH C 233 SITE 3 AC4 11 HOH C 253 HOH C 327 TYR D 3 SITE 1 AC5 9 TYR C 3 HOH C 233 ASP D 1 HIS D 2 SITE 2 AC5 9 CYS D 27 TYR D 28 ARG D 29 HOH D 212 SITE 3 AC5 9 HOH D 294 SITE 1 AC6 10 ARG A 29 HOH A 261 HOH A 266 HOH A 318 SITE 2 AC6 10 ASP C 1 GLY C 25 THR C 26 GOL C 102 SITE 3 AC6 10 HOH C 225 HOH C 282 SITE 1 AC7 11 ASP B 1 GLY B 25 THR B 26 HOH B 314 SITE 2 AC7 11 HOH B 339 ARG C 29 ASN D 4 HOH D 320 SITE 3 AC7 11 HOH D 337 HOH D 350 HOH D 449 SITE 1 AC8 6 ARG A 29 GLY A 30 LYS A 31 HOH A 261 SITE 2 AC8 6 ILE C 23 GLY C 25 SITE 1 AC9 7 TYR A 3 SER A 7 ASP C 1 ASN C 4 SITE 2 AC9 7 SO4 C 108 HOH C 282 HOH C 385 CRYST1 44.817 26.814 58.833 90.00 102.13 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022313 0.000000 0.004796 0.00000 SCALE2 0.000000 0.037294 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017385 0.00000